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An automated microassay was adapted to the study of specific in vitro lymphocyte 
transformation to dinitrochlorobenzene (DNCB) erythrocyte complexes (DNCB-antigen). 
Studies of culture conditions indicated that in flat-bottomed microtiter culture plates, 0.2-ml 
cultures containing 4 x 10'leukocytes and a total culture time of 4 or 5 days yield satisfactory 
results for the relatively low responses seen with specific antigens such as DNCB-antigen. 
Cultures were incubated for 3 hr with tritiated thymidine and harvested with the Multiple 
Automated Sample Harvester (MASH II). 
The effect of DNCB rechallenge on in vitro lymphocyte transformation was studied using 
this automated microassay. DNCB rechallenge boosted the in vitro response to DNCB-anti-
gen, and in leukocyte cultures from some subjects the blastogenic response tended to remain 
elevated longer than has been reported following primary sensitization with DNCB. During a 
primary sensitization with DNCB, in vitro lymphocyte transformation to DNCB-antigen 
converted at about the same time skin reactivity was first observed, usually after about 2 
weeks. However, following patch test rechallenge, skin reactivity was maximal at 2 to 3 days, 
whereas in vitro lymphocyte transformation to DNCB-antigen was nearly undetectable at 2 
to 3 days and increased rapidly during the second week. The induction of lymphokine 
production following patch test rechallenge manifested a time course similar to that observed 
for specific lymphocyte transformation to DNCB-antigen. 
While the reasons for the observed temporal relationships between skin reactivity, 
blastogenesis, and lymphokine production are still unknown, knowledge of these relation-
ships may provide insight on mechanisms of cellular immunity in man. In addition, 
awareness of these temporal relationships may allow a more rational approach to the in vitro 
study of naturally occurring contact sensitizers. 
Dinitrochlorobenzene (DNCB) coupled to pe-
ripheral blood erythrocytes forms a particulate 
complex (DNCB-antigen) which induces lympho-
cyte transformation in leukocyte cultures from 
DNCB-sensitized subjects [1]. Soluble factors or 
lymphokines are released following the addition of 
DNCB-antigen to leukocyte cultures prepared 
from some sensitive subjects. These lymphokines 
induce blastogenesis in target leukocyte popula-
tions from nonsensitized subjects [2,3). In general, 
there is a quantitative correlation between the 
degree of skin reactivity in vivo and lymphocyte 
transformation to DNCB-antigen in vitro [3]. In 
this report we describe the adaptation of a microas-
say (4,5) for the study of lymphocyte transforma-
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tion to specific antigens. Appropriate attention to 
culture conditions has allowed us to reproducibly 
use this microassay to study relatively weak blasto-
genic stimuli such as specific antigens. 
Using this new microassay as well as our previ-
ously reported harvesting method [6], we illustrate 
the effect of DNCB rechallenge on the time course 
of blastogenesis to DNCB-antigen and lymphokine 
production. During the primary immune response 
to DNCB, skin reactivity and the in vitro blasto-
genic response convert at about the same time, 
usually about 2 weeks after initial exposure [1, 7], 
with little or no detectable lymphokine production 
[3]. Rechallenge with DNCB (in subjects sensi-
tized 2 to 10 months previously) induces maximal 
skin reactivity at 2 to 3 days, a significant boost in 
blastogenesis to DNCB-antigen, and lymphokine 
production in some subjects. Detailed time course 
analyses presented in this study show that the 
boost in blastogenesis to DNCB-antigen and the 
initiation of lymphokine production lag behind 
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skin reactivity and are maximal 2 to 3 weeks after 
DNCB rechallenge, when the skin reactivity has 
markedly diminished. The difference in timing 
between skin reactivity, in vitro blastogenesis, and 
lymphokine production following DNCB rechal-
lenge may be due to compartmentalization of 
cutaneous, circulating and central lymphoid tissue 
lymphocytes and may reflect the recirculating 
nature of the small lymphocyte known to play a 
central role in the pathogenesis of allergic contact 
sensitivity [8,9]. 
MATERIALS AND METHODS 
Sensitkation to DNCB. Subjects were sensitized to 
DNCB by previously described methods. A sensitizing 
dose of 2,000 J.lg DNCB in 0.1 ml of acetone was applied to 
the skin of the medial aspect of one or both arms within a 
2-cm diameter polyethylene ring, allowed to evaporate, 
and covered by an adhesive bandage for 2 days [7,10]. 
Rechallenge with DNCB. All subjects were rechal-
lenged with DNCB in a convenient cream base (Acid 
Mantle Creme (aluminum acetate), Dome Laboratories, 
Westhaven, Conn.) under partial occlusion (Johnson & 
Johnsen Sheer Patches) for 2 days. The quantities of 
DNCB were 200 J.lg, 10 J.lg, 1 p.g, 0.1,.g, 0.01J.Ig, 0.001 J.lg. 
Quantitation of skin reactivity. Skin reactivity was 
graded on a 0 to 4+ basis: 0 (no reaction), 1 + (erythema 
only), 2+ (erythema and induration), 3+ (vesicles), 4+ 
(bullae). Patch test reactions were read sequentially on 
an almost daily basis. Skin reactivity for a given day was 
the sum of the grades for all patch test reactions. Thus, 
with a total of 6 different patch test concentrations, the 
maximal skin reactivity would theoretically be 24 if all 6 
concentrations of DNCB gave a 4+ reaction. 
Obtaining mononuclear leukocytes for cultures and for 
frozen storage. Peripheral leukocytes were obtained by a 
centrifugation technique which yields 72 to 92 percent 
lymphocytes and is described in detail elsewhere [11]. 
Briefly. heparinized venous blood was centrifuged at 300 
g for 5 min. The "mononuclear leukocyte-rich plasma" 
was removed with a Pasteur pipette, adjusted to the 
desired cell concentration, and utilized in the preparation 
of leukocyte cultures or stored frozen for later use. The 
methods of freeze-storing leukocytes have been previ-
ously reported [l] and require mixing mononuclear 
leukocyte-rich plasma with Medium 199 and 10% DMSO 
(dimethyl sulfoxide, Aldrich Chemical Co., Milwaukee, 
Wise.) and storage at - 70"C. 
Preparation of leukocyte cultures. Leukocyte cultures 
were prepared ·by diluting the mononuclear leukocyte-
rich plasma obtained above with four parts of tissue 
culture medium (RPMI-1640, Grand Island Biological, 
#187G) containing penicillin and streptomycin. Data 
presented in this report indicate that 0.2-ml cultures in 
microtiter plates are best prepared at a concentration of 2 
x 10' leukocytes per mL DNCB-antigen was prepared 
and added as previously described 11 J at a concentration 
of 25 llg per ml of culture. 
Previously reported studies from this laboratory have 
employed 0.5-ml leukocyte cultures in 35 x 12 mm 
screw-capped vials which were harvested individually hy 
collection on Millipore filters [6]. In this report we use 
0.2-ml cultures in microtiter plates which contain 96 
flat-bottomed wells (Microtest II Tissue Culture Plate, 
catalog #3040, Falcon Plastics, Oxnard, Calif.). Cultures 
were initially prepared in 1-ml volumes and quadrupli-
cate 0.2-ml cultures were transferred to microtiter plates 
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with Finnpipettes (Volumetrics, Inc., Wilmington, 
Mass.). Cultures were incubated in a 5% CO, humidified 
atmosphere at 37°C. As shown in this report, antigen-
stimulated cultures are best harvested after 4 to 5 days of 
total culture time. 
Addition of 'HTdR to microcultures. 'H-Thymidine-
methyl ('HTdR; 17-22 CVmmole; l mCi/ml; Cat No. 
TRK 120, Amersham/Searle, Chicago, Ill.) is added to 
obtain a fmal concentration of 10 p.Ci per ml of culture by 
dispensing 5 lambda aliquots into each 0.2-ml culture 
from a Hamilton repeating syringe (Hamilton Co., Reno, 
Nevada). Our standard procedure, based on data pre-
sented in this report, is to incubate the 0.2-ml cultures 
with 2 p.Ci 'HTdR for the fmal 3 hr of culture. 
Harvesting of 'HTdR-labeled microcultures. After the 
desired length of incubation with 'HTdR, the microtiter 
plates are harvested with the Multiple Automated Sam-
ple Harvester (MASH ll) (Microbiological Associates, 
Bethesda, Md.). The MASH II simultaneously aspirates 
cultures and paases the culture fluid through a sheet of 
glass-fiber filter paper (Reeve Angel, Clifton, N.J.) which 
retains the cells [4,5]. Culture wells are automatically 
rinsed with 0.85 molar, pH 7.2, phosphate buffer by the 
MASH II unit as described by others [4.5]. The filter 
paper is removed, the apparatus rinsed by aspirating 
distilled water through the system, and a new filter paper 
placed on the collecting tray, ready to harvest the next 24 
cultures. Using this method, the entire 96-sample micro-
titer place can be harvested in less than 10 min. When the 
filter paper is removed from the MASH II, circular areas 
corresponding to each of the 24 wells have already been 
partially punched out. The circular pieces of filter paper 
are then easily tapped into clean 35 x 12 mm vials in 
preparation for liquid scintillation spectroscopy. 
Scintillation counting. Filters were counted by a dou-
ble-vial technique reported previously [6]. The 35 x 12 
mm vials containing the filters are placed in a drying 
oven in vacuo at BO"C for 5 min. removed, and allowed to 
cool to room temperature. The dried filter is wetted by 
adding to the vial 1 ml of a scintillation fluid composed of 
20 ml of Liquifluor (New England Nuclear Corp., Boston, 
Mass.) in 1 pint. of toluene. The vial is then screwed into 
its cap which has previously been cemented to the inner 
lining of the cap of a standard scintillation counting vial. 
Radioactivity on the filter within this double-vial appara-
tus is then determined in a Model 4322 Packard Tri-Carb 
Scintillation Spectrometer (Packard Instrument Co., 
Downers Grove, Ill.). 'HTdR incorporation or DNA 
synthesis is expressed as the mean of quadruplicate 
cultures ± standard error. 
Lymphokine supernatant haruest and assay. Details of 
this procedure are published elsewhere [2]. In brief, 
cultures for the production of lymphokine(s) were pre-
pared by culturing leukocytes alone (unstimulated con-
trol cultures) or in the presence of DNCB-antigen 
(DNCB-antigen-stimulated cultures). These cells were 
cultured in 5-ml volumes at 3s•c with room air as the gas 
phase in 60-cc prescription flasks. In studies presented in 
this report, supernatants from these cultures were har-
vested by centrifugation at 48 br and were filtered 
through 0.45-J.I Millipore filters (Millipore Corp., Bed-
ford, Mass.). Assay of lymphokine activity involved the 
addition of supernatants of stimulated and unstimulated 
primary cultures to secondary target leukocyte cultures 
prepared from subjects not sensitized to DNCB. The 
concentration of leukocytes was maintained constant 
within each experiment. Secondary cultures in these 
lymphokine experiments were cultured in 0.5-ml volumes 
at as•c with room air as the gas phase in 12 x 35 mm 
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screw-capped vials with primary supernatants constitut-
ing 80 to 90% of the secondary target leukocyte cultUl'es. 
RESULTS 
Microassay 
Previous studies have emphasized the impor-
tance of incubation time when radionuclide incor-
poration is used as a measure of blastogenesis [6). 
It is required that the incubation time be long 
enough to produce sufficient counts to allow quan-
titative comparisons. However, it is necessary that 
the incubation time not be prolonged to the point 
that cultures with high rates of incorporation are 
incorporating at less than the initial rate. Figure 1 
shows that 'HTdR incorporation increases linearly 
in DNCB-antigen-stimulated microcultures dur-
ing the first 5 hr of incubation. Microcultures 
containing 3 x 10• leukocytes per ml incorporated 
more 'HTdR than those containing 2 x 10"leuko-
cytes per ml, but at very high concentrations (10 x 
10") there was considerably less incorporation (Fig. 
1). 
In addition to the 'HTdR incubation time, the 
total culture time or day of harvest is an important 
consideration in making valid quantitative com-
parisons. In most human systems it has been found 
best to harvest antigen-stimulated cultures after a 
total culture time of greater than 4 days, whereas 
with a powerful mitogenic stimulus such as phy-
tohemagglutinin, maximal incorporation is found 
under most culture conditions as early as the 2nd 
or 3rd day [12]. Culture conditions such as cell 
concentration, cell density, and stimulant concen-
tration can effect the kinetics of radionuclide 
incorporation. Figure 2 shows that under the cul-
ture conditions employed in our microassay, 
'HTdR incorporation increased with increasing 
cell concentrations up to 3 x 10" and with increas-
ing culture time at least up to 6 days. Addition of 
Hepes buffer to the RPMI 1640 culture medium 
did not significantly affect 'HTdR incorporation, 
and microtiter plates with wells shaped differently 
than the flat-bottomed plates used in the above 
experiments could also be used, but alterations in 
cell density might require concomitant alterations 
of other culture conditions (unpublished data). As 
a result of the above experiments, we selected a 
3-hr 'HTdR incubation time, a total culture time 
of 4 or 5 days, and a cell concentration of 2 x 10" 
leukocytes per ml in flat-bottomed microtiter cul-
ture plates. 
Temporal Relationships of Skin Reactivity and 
Specific In Vitro Blastogenesis 
Figure 3 shows the temporal relationship be-
tween skin reactivity to DNCB and in vitro blasto-
genesis to DNCB-antigen in 4 subjects who had 
been sensitized to DNCB 2 to 10 months before 
rechallenge. On day 0 each of the 4 subjects was 
rechallenged with DNCB dilutional patch tests 
(see Materials and Method~). Each patch test was 
l•IO" 
FIG. 1. Effect of 'HTdR incubation time and cell 
concentration on the measurement of blastogenesis to 
DNCB-antigen in microcultures. Leukocyte cultures 
from a DNCB-sensitive subject were prepared in micro-
titer plates at different cell concentrations (0.5, l, 2, 3, 
and 10 x lO"leukocytes/ml) for a total culture time of 5 
days and 'HTdR added for the final 1, 2, 3, and 5 hr. 
Vertical bars represent standard errors of quadruplicate 
cultures. 
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FIG. 2. Effect of total culture time and cell concentra-
tion on 'HTdR incorporation as a measurement of blas-
togenesis to DNCB-antigen in microcultures. Leukocyte 
cultures from a DNCB-sensitive subject were prepared in 
microtiter plates at different cell concentrations for a 
total culture time of 3, 4, and 6 days. "HTdR incubation 
time was 3 hr for all cultures. Vertical bars represent 
standard errors of quadruplicate cultures. 
graded 0 to 4+ and skin reactivity is expressed as 
the sum of all patch test grades. In addition, blood 
was drawn at intervals before and after patch test 
rechallenge and leukocytes were stored frozen [1]. 
At a later time, leukocytes were thawed from each 
day of collection and lymphocyte transformation to 
DNCB-antigen was measured with the microassay 
technique outlined above. 
In all 4 subjects, skin reactivity to DNCB was 
maximal at 2 to 3 days and was declining rapidly 
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FIG. 3. Effeet of DNCB rechallenge on skin reactivity and specific blastogenesis. Four subjects (A, B, C, D) who had 
been initially sensitized 2 to 10 months earlier were rechallenged with DNCB on day 0. Skin reactivity represents the 
sum of the scores of dilutional patch test. Leukocyte cultures were prepared from frozen stored samples obtained on 
the indicated days before and after DNCB rechallenge. 
by the second week. In contrast to the skin 
reactivity to DNCB, in vitro blastogenesis to 
DNCB-antigen was nearly undetectable at 2 days, 
was increasing rapidly during the second week, and 
was not maximal until the third week, at which 
time skin reactivity had greatly diminished. Some 
subjects studied in this sequential manner main-
tained high levels of blastogenesis to DNCB-anti-
gen for several months or more after rechallenge 
with DNCB, whereas others (e.g., subjects C and 
D, Fig. 3) showed a decline of in vitro blastogenesis 
similar to the decline observed following primary 
seJJSitization [1]. 
Temporal Relationships of Skin Reactivity and in 
Vitro Lymphokine Production 
Figure 4 shows the temporal relationships be-
tween skin reactivity to DNCB and in vitro lym-
phokine production. On day 0 each of the 3 
subjects was rechallenged with dilutional DNCB 
patch tests as described above. In addition, blood 
was drawn at varying intervals before and after 
patch test rechallenge, and fresh leukocyte cul-
tures with and without DNCB-antigen were pre-
pared in 60-cc prescription flasks. Mter 48 hr of 
culture time the supernatants from these primary 
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FIG. 4. Effect ofDNCB rechallenge on skin reactivity and lymphokine production. Three subjects (A, B, C) who had 
been initially sensitized 2 months earlier were rechallenged with DNCB on day 0. Skin reactivity represents the sum of 
the scores of dilutional patch tests. Primary leukocyte cultures for lymphokine production were prepared on each of 
the days indicated and cell-free supernatants were collected after 48 hr of primary culture time and stored at 4 oc. 
cultures were harvested, rendered cell-free by fil-
tration, and stored at 4 oc (see Materials and 
Methods). After the final supernatant collection, 
secondary target cultures using leukocytes from a 
subject not sensitive to DNCB were prepared. 
Stimulated and unstimulated control superna-
tants of primary cultures from the subject who had 
undergone DNCB rechallenge were added to the 
secondary target cultures. 
Again, in all subjects, skin reactivity to DNCB 
was maximal at 2 to 3 days and was declining 
rapidly during the second week. In contrast to the 
skin reactivity to DNCB, lymphokine production 
was undetectable at 2 days and was increasing at a 
time when the skin reactivity had greatly dimin-
ished. The time course of lymphokine production 
in these subjects was similar to the increase of 
blastogenesis to DNCB-antigen shown above. 
This close association between lymphokine pro-
duction and specific blastogenesis does not always 
hold, as we have previously reported the absence of 
significant lymphokine production in the presence 
of high levels of blastogenesis to DNCB-antigen 
during initial sensitization with DNCB. Further-
more, not all subjects show detectable lymphokine 
production even after rechallenge with DNCB [3]. 
However, while specific blastogenesis in the ab-
sence of detectable lymphokine has been observed, 
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we have not observed lymphokine production in 
the absence of significant blastogenesis. 
DJSCUSSION 
Appropriate use of the Multiple Automated 
Sample Harvester (MASH IT) offers a significant 
technical advance for in vitro studies of immune 
function. Our results indicate that with careful 
attention to cell concentration, "HTdR incubation 
time, and total culture time in microtiter plates, 
the MASH II device can be adapted to the study of 
relatively weak blastogenic stimulation seen with 
specific antigens such as DNCB-antigen. For re-
sponses of such magnitude, 0.2-ml cultures con-
taining 2 million leukocytes per ml with a 3-hr 
'HTdR incubation time, harvested after 4 or 5 days 
of total culture time, yield satisfactory results and 
assurance of some latitude in detecting a response 
if any of the parameters is altered. For more potent 
blastogenic stimuli such as phytohemagglutinin or 
other mitogens, other culture conditions and tim-
ing may be required [12). 
For purposes of assessing antigenic lymphocyte 
stimulation, the microassay offers several distinct 
advantages over previous methods. Firstly, the 
most significant advantage is the rapidity with 
which a large number of samples can be easily 
handled in a short period of time, e.g., more than 
100 leukocyte cultures can be harvested by one 
person in less than 10 min. Secondly, it is our 
impression that generally, though not invariably, 
the microassay shows Jess variation between repli-
cate cultures which, as with many biologic assays, 
has been a significant problem with previously 
employed leukocyte culture methods. Finally, the 
small culture volumes require fewer cells and 
smaller quantities of antigen or other stimuli which 
may be in short supply or difficult to obtain, e.g., 
certain biologically active lymphocyte products 
such as lymphokines. This improved microassay 
allows the practical screening for sensitivities to a 
large panel of antigens. Thus, if some of the 
methods used in studying allergic contact dermati-
tis to DNCB prove applicable to other contact 
allergens, current leukocyte culture technology 
should provide a practical in vitro screening 
method for contact sensitivity. 
In addition to potential practical applications, 
this rapid and precise microassay has allowed us to 
more easily extend previously reported preliminary 
observations on the effect of DNCB rechallenge on 
specific in vitro blastogenesis [1 ]. In contrast to the 
close association between skin reactivity and spe-
cific in vitro blastogenesis observed during initial 
sensitization with DNCB {1, 7], we observed the 
time course of these phenomena to be separate and 
distinct following DNCB rechallenge. In healthy 
human subjects, skin reactivity following DNCB 
rechallenge was maximal after only 2 to 3 days, the 
usual time for patch test reading. DNCB rechal-
lenge markedly boosted specific in vitro blas-
togenesis, but the increase was not apparent untill 
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to 2 weeks after rechallenge. Like the specific 
blastogenic response to DNCB-antigen, lympho-
kine production occurs following in vivo DNCB 
rechallenge at a predictable interval and is still 
increasing at a time when skin reactivity is de-
creasing. 
The time course of lymphokine production fol-
lowing DNCB rechallenge generally parallels the 
induction of blastogenesis. However, during initial 
sensitization and in some subjects following subse-
quent rechallenge with DNCB, no lymphokine 
production has been detected while high levels of 
specific blastogenesis are observed [3]. We inter-
pret this to indicate that blastogenic lymphokine 
production may represent an immune amplifying 
mechanism since we have not observed lympho-
kine production in the absence of specific blas-
togenesis. This is not to say that lymphokine 
production is dependent on cell proliferation per 
se. Indeed some products of lymphocyte-antigen 
interaction have been shown to be independent of 
the proliferative response [13]. 
The temporal relationships between skin reac-
tivity, blastogenesis, and lymphokine production 
following DNCB rechallenge might be due to a 
compartmentalization of lymphocytes at varying 
periods following antigenic rechallenge. For exam-
ple, circulating, antigenically reactive cells might 
go directly into the skin following DNCB rechal-
lenge, followed by a lymphatic return to regional 
nodes and a subsequent shower in the peripheral 
circulation pool after a 1- to 2-week lag. Our in 
vitro studies are carried out on leukocytes from the 
peripheral blood circulating pool which at any 
given time may or may not reflect the same 
reactivity as leukocytes present in the skin or 
central lymphoid tissues. In addition to recircula-
tion and compartmentalization as an explanation 
for our observations, it is possible that long-lived 
memory lymphocytes are constantly circulating, 
but are not detected by the in vitro antigen-
stimulated proliferative response until a popula-
tion of shorter-lived proliferative cells are produced 
by the stimulation of DNCB rechallenge. What-
ever the reasons for the observed temporal relation-
ships between skin reactivity, blastogenesis, and 
lymphokine production, the in vitro and in vivo 
phenomena are both a consequence of rechallenge 
with DNCB. 
Some of the methods used for the study of 
experimental contact sensitivity may be adaptable 
to allergens responsible for clinical contact derma-
titis. Thus, in addition to providing possible in-
sight on mechanisms of cell-mediated immunity in 
man, these studies may provide a more rational 
approach to the in vitro study of naturally occur-
ring contact sensitizers where exposure is uncon-
trolled and temporal relationships similar to those 
seen with DNCB may be anticipated. 
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